Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
5 Ergebnisse für "guideline" unter Roche Glycart AG
Elecsys® CA 125 II
... . Version 1.2020 NICE (National Institute for Health and Clinical Exellence) Clinical Guideline: Ovarian ... Guideline 122. Ledermann J.A. et al. (2013) Annals of Oncology 24 (Supplement 6): vi24–vi32, 2013 Moore, R.G ... . Version 1.2020 NICE (National Institute for Health and Clinical Exellence) Clinical Guideline: Ovarian ... Guideline 122. Ledermann J.A. et al. (2013) Annals of Oncology 24 (Supplement 6): vi24–vi32, 2013 Moore, R.G ...
VENTANA HER2 Dual ISH DNA Probe Cocktail Assay (CE IVD)
... Practice Guideline Update. J Clin Oncol.2013;31(31):3997-4013. Bang YJ, Van Cutsem E, Feyereislova A, et ... Clinical Practice Guideline Focused Update. Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB ... . ASCO/CAP Clinical Practice Guideline Update. J Clin Oncol.2013;31(31):3997-4013. Bang YJ, Van Cutsem E ... Pathologists Clinical Practice Guideline Focused Update. Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu ...